APTO logo

Aptose Biosciences (APTO) Short Term Debt

Annual Short Term Debt

$394.00 K
+$93.00 K+30.90%

31 December 2023

APTO Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Short Term Debt

$416.00 K
+$12.00 K+2.97%

30 September 2024

APTO Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

APTO Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+30.9%+6.7%
3 y3 years-26.9%-13.7%
5 y5 years+100.0%-18.9%

APTO Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-26.9%+30.9%-19.9%+54.1%
5 y5 years-26.9%-22.8%+54.1%
alltimeall time-97.0%-96.9%

Aptose Biosciences Short Term Debt History

DateAnnualQuarterly
Sept 2024
-
$416.00 K(+3.0%)
June 2024
-
$404.00 K(+1.3%)
Mar 2024
-
$399.00 K(+1.3%)
Dec 2023
$394.00 K(+30.9%)
$394.00 K(+1.0%)
Sept 2023
-
$390.00 K(+0.8%)
June 2023
-
$387.00 K(+26.5%)
Mar 2023
-
$306.00 K(+1.7%)
Dec 2022
$301.00 K(-34.4%)
$301.00 K(+11.5%)
Sept 2022
-
$270.00 K(-32.2%)
June 2022
-
$398.00 K(-23.3%)
Mar 2022
-
$519.00 K(+13.1%)
Dec 2021
$459.00 K(-14.8%)
$459.00 K(-4.8%)
Sept 2021
-
$482.00 K(-5.1%)
June 2021
-
$508.00 K(-4.2%)
Mar 2021
-
$530.00 K(-1.7%)
Dec 2020
$539.00 K(+3.5%)
$539.00 K(+0.4%)
Sept 2020
-
$537.00 K(+1.7%)
June 2020
-
$528.00 K(+0.6%)
Mar 2020
-
$525.00 K(+0.8%)
Dec 2019
$521.00 K(>+9900.0%)
$521.00 K(+1.6%)
Sept 2019
-
$513.00 K(+4.1%)
June 2019
-
$493.00 K(+1.6%)
Mar 2019
-
$485.00 K(>+9900.0%)
DateAnnualQuarterly
Dec 2018
$0.00(-100.0%)
$0.00(-100.0%)
June 2015
-
$229.60 K(+5.1%)
Mar 2015
-
$218.50 K(-55.3%)
Dec 2014
$353.20 K(-59.6%)
-
Sept 2014
-
$488.30 K(-38.7%)
Feb 2014
-
$797.20 K(-1.9%)
Nov 2013
-
$812.90 K(+2.1%)
Aug 2013
-
$795.90 K(>+9900.0%)
Feb 2013
-
$0.00(0.0%)
Nov 2012
-
$0.00(0.0%)
Aug 2012
-
$0.00(-100.0%)
May 2012
$873.40 K(>+9900.0%)
$873.40 K(+189.5%)
Feb 2012
-
$301.70 K(>+9900.0%)
Nov 2011
-
$0.00(0.0%)
Aug 2011
-
$0.00(0.0%)
May 2011
$0.00(-100.0%)
$0.00(0.0%)
Feb 2011
-
$0.00(0.0%)
Nov 2010
-
$0.00(-100.0%)
Aug 2010
-
$1.41 M(+49.3%)
May 2010
$947.80 K(-92.8%)
$947.80 K(-92.8%)
May 2009
$13.26 M
$13.26 M(+20.9%)
Feb 2009
-
$10.96 M(+0.8%)
Nov 2008
-
$10.88 M(+20.1%)
Nov 2005
-
$9.06 M

FAQ

  • What is Aptose Biosciences annual short term debt?
  • What is the all time high annual short term debt for Aptose Biosciences?
  • What is Aptose Biosciences annual short term debt year-on-year change?
  • What is Aptose Biosciences quarterly short term debt?
  • What is the all time high quarterly short term debt for Aptose Biosciences?
  • What is Aptose Biosciences quarterly short term debt year-on-year change?

What is Aptose Biosciences annual short term debt?

The current annual short term debt of APTO is $394.00 K

What is the all time high annual short term debt for Aptose Biosciences?

Aptose Biosciences all-time high annual short term debt is $13.26 M

What is Aptose Biosciences annual short term debt year-on-year change?

Over the past year, APTO annual short term debt has changed by +$93.00 K (+30.90%)

What is Aptose Biosciences quarterly short term debt?

The current quarterly short term debt of APTO is $416.00 K

What is the all time high quarterly short term debt for Aptose Biosciences?

Aptose Biosciences all-time high quarterly short term debt is $13.26 M

What is Aptose Biosciences quarterly short term debt year-on-year change?

Over the past year, APTO quarterly short term debt has changed by +$26.00 K (+6.67%)